Regulatory Notification on High Lead and Mercury Levels in Unregistered Traditional Medicines Sold by Yuthok Traditional Pharmacy
Home Regulatory news and announcements, Regulatory news and notificationsRegulatory Notification on High Lead and Mercury Levels in Unregistered Traditional Medicines Sold by Yuthok Traditional Pharmacy

Regulatory Notification on High Lead and Mercury Levels in Unregistered Traditional Medicines Sold by Yuthok Traditional Pharmacy

December 15, 2025| Regulatory news and announcements, Regulatory news and notifications|

Regulatory Notification on High Lead and Mercury Levels in Unregistered Traditional Medicines Sold by Yuthok Traditional PharmacyDownload

Last modified: April 8, 2026

Previous:
Public Consultation on “National Vigilance Strategy for Medical Products 2025”
Next:
BFDA Public Health Advisory on high Lead and Mercury contains in unregistered traditional medicine (Rinchen Jumar 25) sold by Yuthok Traditional Pharmacy

Comments are closed.

Close Search Window
↑